Wednesday, April 16 2014 10:54 PM EDT2014-04-17 02:54:16 GMT
LOUISVILLE, Ky. (WDRB) --The Rangers are the Army's most elite soldiers who are put into some of the most dangerous situations in Afghanistan. In a story you'll only see on WDRB we got a rare look atMore >>
The Army Rangers choose Fort Knox as the location to prepare for the 3rd Battalion's 20th deployment to Afghanistan.More >>
Follow the WDRB Newsroom, Reporters and Anchors.More >>
Tweets from the WDRB Newsroom, Reporters and Anchors.More >>
LOUISVILLE, Ky. (WDRB) -- The University of Louisville is celebrating a move that will help its research program to save lives around the world.
University officials announced Wednesday that renowned U of L researcher Suzanne Ildstad and her company Regenerex have entered into an agreement with pharmaceutical giant Novartis.
It's hoped the move will enable stem-cell technology developed by Ildstad and her team to prevent rejection of kidney transplants to be made available worldwide much sooner.
"We needed to commercialize it to make it widely available. And, we're really optimistic that through the collaboration with Novartis we'll be able to do that. And, it's just fantastic to be planning to have a worldwide initiative and move into a pivotal trial through the kidneys and possibly the metabolics in very short order," Ildstad told reporters.
It's also hoped Novartis will use the U of L research to develop treatments for other diseases.